Brief: Monopar Initiates Clinical Trial Of Novel uPAR-Targeted Radiopharmaceutical Therapy In Advanced Cancers
07/10/2024 13:16
Oct 7 (Reuters) - Monopar Therapeutics Inc MNPR.O :
* MONOPAR INITIATES CLINICAL TRIAL OF NOVEL UPAR-TARGETED
RADIOPHARMACEUTICAL THERAPY IN ADVANCED CANCERS
* MONOPAR THERAPEUTICS INC - PHASE 1A TRIAL FOR MNPR-101-LU
NOW
ACTIVE
Source text for Eikon: ID:nGNX1jmv8S
Further company coverage: MNPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Monopar Therapeutics
See all newsBrief: Monopar Appoints Jeffrey D. Kent, M.D., As Executive Vice President, Head Of Medical Affairs Announces Two Alxn1840 Presentations At Aasld – The Liver Meeting 2026
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Monopar Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Monopar Therapeutics Inc. expected to post a loss of 62 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Alphabet, IBM, Tesla